Phase 1 Clinical Trial of DA-5207 in Healthy Adults
NCT05127746
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Aricept 5mg Tablet
DRUG:
Aricept 10mg Tablet
DRUG:
DA-5207 A
DRUG:
DA-5207 B
Sponsor
Dong-A ST Co., Ltd.